Abstract
The aim of this study was to determine if increased mortality associated with low levels of serum 25-hydroxyvitamin D (25(OH)D) reflects a causal relationship by using a Mendelian randomisation (MR) approach with genetic variants in the vitamin D synthesis pathway. Individual participant data from three European cohorts were harmonized with standardization of 25(OH)D according to the Vitamin D Standardization Program. Most relevant single nucleotide polymorphisms of the genes CYP2R1 (rs12794714, rs10741657) and DHCR7/NADSYN1 (rs12785878, rs11234027), were combined in two allelic scores. Cox proportional hazards regression models were used with the ratio estimator and the delta method for calculating the hazards ratio (HR) and standard error of genetically determined 25(OH)D effect on all-cause mortality. We included 10,501 participants (50.1% females, 67.1±10.1 years) of whom 4003 died during a median follow-up of 10.4 years. The observed adjusted HR for all-cause mortality per decrease in 25(OH)D by 20 nmol/L was 1.20 (95% CI: 1.15–1.25). The HR per 20 nmol/L decrease in genetically determined 25(OH)D was 1.32 (95% CI: 0.80–2.24) and 1.35 (95% CI of 0.81 to 2.37) based on the two scores. In conclusion, the results of this MR study in a combined sample from three European cohort studies provide further support for a causal relationship between vitamin D deficiency and increased all-cause mortality. However, as the current study, even with ~10,000 participants, was underpowered for the study of the effect of the allele score on mortality, larger studies on genetics and mortality are needed to improve the precision.
Original language | English |
---|---|
Article number | 74 |
Pages (from-to) | 1-12 |
Number of pages | 12 |
Journal | Nutrients |
Volume | 11 |
Issue number | 1 |
Early online date | 2 Jan 2019 |
DOIs | |
Publication status | Published - Jan 2019 |
Funding
21 Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Biostatistics, Amsterdam Public Health, 1081 Amsterdam, The Netherlands; [email protected] (K.M.A.S.); [email protected] (N.M.v.S.) 22 Department of Health Sciences, Faculty of Sciences and Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, 1081 Amsterdam, The Netherlands; [email protected] 23 Department of Internal Medicine, Endocrine Section, VU University Medical Center, Funding: Age, Gene/Environment Susceptibility Reykjavik Study: This study has been funded by NIH contract N01-AG012100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament), an Intramural Research Program Award (ZIAEY000401) from the National Eye Institute, an award from the National Institute on Deafness and Other Communication Disorders (NIDCD) Division of Scientific Programs (IAA Y2-DC_1004-02), The study is approved by the Icelandic National Bioethics Committee, VSN: 00-063. Ludwigshafen RIsk and Cardiovascular Health Study: None. Tromsø Study: None.
Funders | Funder number |
---|---|
Division of Scientific Programs | 00-063 |
National Institutes of Health | N01-AG012100 |
National Institute on Aging | |
National Eye Institute | ZIAEY000401 |
National Institute on Deafness and Other Communication Disorders | IAA Y2-DC_1004-02 |
Hjartavernd |
Keywords
- Cohorts
- Individual participant data
- Mendelian randomization
- Mortality
- Standardized 25(OH)D
- Vitamin D